scispace - formally typeset
Journal ArticleDOI

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.

Reads0
Chats0
TLDR
The present study represents that the combination of HFD-fed and low-dose STZ-treated rat serves as an alternative animal model for type 2 diabetes simulating the human syndrome that is also suitable for testing anti-diabetic agents for the treatment of type 1 diabetes.
About
This article is published in Pharmacological Research.The article was published on 2005-10-01. It has received 1573 citations till now. The article focuses on the topics: Insulin resistance & Glucose tolerance test.

read more

Citations
More filters
Journal ArticleDOI

Neuroprotective effect of epalrestat mediated through oxidative stress markers, cytokines and TAU protein levels in diabetic rats.

TL;DR: The findings suggest that diabetic rats treated with epalrestat could ameliorate the cognition deficits and might act as a beneficial agent for prevention and treatment of cognitive impairment in diabetes.
Journal ArticleDOI

Inhibition of the hepatic glucose output is responsible for the hypoglycemic effect of Crataegus aronia against type 2 diabetes mellitus in rats

TL;DR: In conclusion, C. aronia ameliorates T2DM by inhibiting hepatic glucose output, responsible for the hypoglycemic effect of Crataegus aronia against type 2 diabetes mellitus in rats.
Journal ArticleDOI

L-ergothioneine and its combination with metformin attenuates renal dysfunction in type-2 diabetic rat model by activating Nrf2 antioxidant pathway.

TL;DR: In this paper, the effect of L-ergothioneine (L-egt) alone or combined with metformin on renal damage in a type-2 diabetic (T2D) rat model was investigated.
References
More filters
Journal ArticleDOI

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.

TL;DR: How advances in the understanding of nuclear receptor function, particularly the docking of cofactors in a ligand-dependent fashion, should lead to improved drugs that utilize the PPAR-gamma system for the treatment of insulin resistance is discussed.
Journal ArticleDOI

Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

TL;DR: Clinical studies in patients with type II diabetes, as well as other syndromes characterized by insulin resistance, have demonstrated that thiazolidinediones may represent a safe and effective new treatment.
Journal ArticleDOI

A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

TL;DR: Fat-fed/STZ rats provide a novel animal model for type 2 diabetes, simulates the human syndrome, and is suitable for the testing of antidiabetic compounds.
Related Papers (5)